Erik Andersson

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Probac AB manufactures, markets, and licenses probiotic products. Its product development takes place in three different areas: ear-nose-throat; gastrointestinal tract; and the immune system. The firm offers probiotic strains designed for different applications in provisions and pharmaceuticals. Its product Probactiv svalg, contains bacteria normally present in the throat. The company was founded by Eva Grahn Hakansson and Waldemar Nyström in 2005 and is headquartered in Umea, Sweden.

BrainCool AB engages in the development, marketing, and trade of medical cooling systems for the healthcare sector. It operates through the Brain Cooling and Pain Management business areas. The firm's products include BrainCool™ System and RhinoChill™ System that facilitates rapid medical cooling treatment in an emergency setting for stroke and sudden cardiac arrest patients. The company was founded by Christian Strand in 2010 and is headquartered in Lund, Sweden.

InfiCure Bio AB operates as a life science company. It focuses on preclinical development and validation of drugs. The company was founded by Dan Holmberg and Sofia Mayans in 2015 and is headquartered in Umea, Sweden.